期刊文献+

SNCG在膀胱癌中的表达及临床意义 被引量:3

SNCG expression and clinical significance in bladder carcinoma
下载PDF
导出
摘要 目的探讨SNCG在膀胱癌中的表达情况及其临床意义。方法收集2006年1月至2009年12月中国医学科学院北京协和医院收治的140例具有完整临床病理及随访资料的膀胱癌手术标本,采用免疫组织化学染色检测SNCG在膀胱癌中的表达情况,分析SNCG表达与膀胱癌临床病理特征及预后的关系。结果膀胱癌组织中SNCG的阳性表达率为90.7%(127/140),而癌旁组织中无表达(0/68),差异有统计学意义(P〈0.05)。Logistic多因素分析显示,SNCG的表达是膀胱癌复发的独立因素(HR=2.044,95%CI:1.114~3.752,P〈0.05);SNCG阴性表达者术后无病生存期(DFS)和总生存期(OS)分别为(78.7±4.2)个月(95%CI:70.5~86.9个月),(80.3±4.0)个月(95%CI:72.4~88.2个月),而SNCG阳性表达者DFS和OS分别为(48.7±5.4)个月(95%CI:38.1~59.3个月),(51.1±5.2)个月(95%CI:40.9~61.2个月),差异无统计学意义(P=0.821,0.544);COX多因素显示SNCG与膀胱癌预后无关。结论 SNCG在膀胱癌组织中高表达,且与膀胱癌复发相关,但不能作为膀胱癌预后的独立预测因子。 Objective To explore the expression of SNCG in bladder carcinoma and its clinical significance.MethodsSurgical specimens were collected from140 bladder carcinoma patients with complete clinical and follow-up data during Jan.2006 and Dec.2009.SNCG expression was identified immunohistochemically in whole tissue sections.Association of SNCG expression with clinicopathologic factors and prognosis of bladder carcinoma were accessed.Results The positive rate of SNCG expression was 90.7%(127/140)in bladder carcinoma,while no SNCG expression was observed in pericarcinous tissues,and the difference was statistically significant(P〈0.05).Logistic regression analysis showed that SNCG expression was an independent factor associated with the recurrence of bladder cancer(HR=2.044,95%CI,1.114-3.752,P〈0.05);the DFS and OS of the SNCG-negative patients were(78.7±4.2)months(95%CI,70.5-86.9 months),and(80.3±4.0)months(95% CI,72.4-88.2 months),respectively;for the SNCG-positive patients,the DFS and OS reduced to(48.7±5.4)months(95%CI,38.1-59.3 months),and(51.1±5.2)months(95%CI,40.9-61.2 months),respectively(P=0.821 and 0.544),and there was no statistically significant difference.Multivariate COX analysis showed there was no association between the prognosis of the bladder carcinoma and SNCG expression.Conclusion SNCG is highly expressed in bladder cancer tissue and its expression indicates a high recurrence rate,but it is not helpful to predict the prognosis of bladder cancer.
出处 《现代泌尿外科杂志》 CAS 2016年第6期427-432,共6页 Journal of Modern Urology
关键词 SNCG 膀胱癌 复发 预后 synuclein-γ bladder carcinoma recurrence prognosis
  • 相关文献

参考文献21

  • 1COLOMBEL M,SOLOWAY M, AKAZA H,et al. “Epidemiology, staging, grading, and risk stratification of bladder cancer” [J]. Eur Urol,2008,7(Suppl 10):618626.
  • 2FERLAY J, SOERJOMATARAM I, ERVIK M, et al. Globocan 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.Lyon[C]. France: International Agency for Research on Cancer,2013:20.
  • 3KARAOGLU I, VAN DER HEIJDEN AG, WITJES JA. The role of urine markers, white light cystoscopy and florescence cystoscopy in recurrence, progression and followup of nonmuscle invasive bladder cancer [J]. World J Urol, 2014, 32(3): 651-659.
  • 4CHADE DC, SHARIAT SF, GODOY G, et al. Critical review of biomarkers for the early detection and surveillance of bladder cancer [J]. J Mens Health, 2009, 6(4): 368-382. .
  • 5FEI YE, LI WANG, MIREIA CASTILLOMARTIN, et al. Biomarkers for bladder cancer management: present and future [J]. Am J Clin Exp Urol, 2014, 2(1):1-14. .
  • 6JI H, LIU YE, JIA T, et al. Identification of a breast cancerspecific gene, BCSG1, by direct differential cDNA sequencing [J]. Cancer Res, 1997, 57(4): 759-764. .
  • 7LIU H, LIU W, WU Y, et al. Loss of epigenetic control of synucleingamma gene as a molecular indicator of metastasis in a wide range of human cancers [J]. Cancer Res, 2005, 65(17): 7635-7643.
  • 8WU K, HUANG S, ZHU M, et al. Expression of synuclein gamma indicates poor prognosis of triplenegative breast cancer [J]. Med Oncol, 2013, 30(3): 612-612. .
  • 9HIBI T, MORI T, FUKUMA M, et al. Synucleingamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer [J]. Clin Cancer Res, 2009, 15(8): 2864-2871.
  • 10AMSTERDAM A, SHEZEN E, RAANAN C, et al. Differential staining of gamma synuclein in poorly differentiated compared to highly differentiated colon cancer cells [J]. Oncol Rep,2012,27(5):1451-1454.

同被引文献17

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部